Dale Thomas

Adimab LLC provides human therapeutic antibodies. The firm has discovered antibodies for a wide variety of therapeutic targets within many disease areas, including oncology, immunomodulation, inflammation, neuroscience and pain, cardiovascular and metabolic disease and infectious disease. The company was founded in 2007 by Tillman Gerngross, Dane Wittrup and Errik Anderson and is headquartered in Lebanon, NH.

Wheeler Bio, Inc. is a biomanufacturing company based in the biomanufacturing metro of Oklahoma City, OK. Wheeler Bio's technology platform, Portable CMC™, simplifies the path between drug discovery and clinical manufacturing, providing a new bridge for translating discoveries to first-in-human trials. The company's hub-and-spoke operational model, integrated with biotechs and discovery CROs, revolutionizes the speed of drug development. Wheeler Bio offers a different CDMO model to help innovators go faster with candidates, accelerating processes for plasmids, cell lines, characterization, and more. The company's biologics CDMO facility offers protein expression, cell line development, process development, analytical development, and material supply and testing capabilities. The company was founded by a team of industry experts and strategic investors, led by Jesse McCool who has been the CEO since incorporation.

Lapix Therapeutics, Inc. is a company located in the US that is focused on developing new therapies for autoimmune diseases and oncology. The American company's approach involves creating orally bioavailable immune system restoration therapies that are designed to be effective and easy to use.

Elektrofi, Inc. operates as a biotechnology company that focuses on drug formulation innovations. The firm offers revolutionary protein formulations, high-tech processing and modern applications and value across the healthcare ecosystem. The company was founded by Chase Coffman and Jason Norris in 2016 and is headquartered in Boston, MA.

New Valence Robotics Corp. provides automated three-dimensional 3D printing solutions. Its products include hardware, software and materials. The firm solutions include business, education and resellers. The company was founded by AJ Perez, Forrest Pieper, Mateo Peña Doll and Chris Haid and is headquartered in Boston, MA.

Digital Alloys, Inc. engages in the development of metal additive manufacturing systems. Its Joule Printing machine is used to cut and design tool steel, titanium, and multi-metal parts. The company was founded in 2017 and is headquartered in Burlington, MA.

Ulysses Diversified Holdings LLC functions as an investment fund.

Alloy Therapeutics LLC is a biotechnology ecosystem company that democratizes access to tools, technologies, services, and company creation capabilities for discovering and developing therapeutic biologics. The company's lead offering is the ATX-GX™ platform, a human therapeutic antibody discovery platform consisting of a growing suite of proprietary transgenic mice strains. Through a community of partners across academia, biotech, and the largest biopharma, Alloy is a leader in bispecific antibody discovery and engineering services, utilizing its proprietary ATX-CLC common light chain platform integrating novel transgenic mice and phage display. Founded in 2017 and privately funded by visionary investors, Alloy is headquartered in Hanover, NH, with European labs in Switzerland. The company was founded by Errik B. Anderson, who has been the CEO since incorporation.

Vernal Biosciences, Inc. is a fully integrated contract development and manufacturing organization (CDMO) that specializes in manufacturing and formulating mRNA and LNP-mRNA. Vernal's focus is on democratizing access to their expertise and unparalleled LNP-platform technologies to accelerate the potential of mRNA. The American company provides comprehensive high purity platform manufacturing solutions for mRNA-based medicines, from research to clinical development. Vernal Biosciences is pioneering the custom development and manufacturing process for a variety of applications including vaccine development, gene replacement, and more. The company was founded in 2021 and is headquartered just outside of an undisclosed location. The company was founded by Cobaugh Christian, who has been the CEO since incorporation.

Compass Therapeutics LLC operates as a healthcare industry focusing on biotechnology. It offers drug discovery, development, biologics, oncology and immuno-oncology. The company was founded by Errik B. Anderson and Thomas J. Schuetz in 2014 and is headquartered in Cambridge, MA.

ClutchRetail, Inc. provides an internet website portal connecting shoppers with retailers. It enables users to find a product; set a desired price and see the product price change over time; and get an email when price drops below their desired price. The firm also provides price updates and graphs of products that are selected by users; and share useful collections to help friends. The company was founded by Abe Gurjal, Greg A. Kimball and Nathan A. Sharp in 2012 and is headquartered in Boston, MA.

Avitide, Inc. develops affinity purification solutions. Its technology enables development of chromatography resins via chemical synthesis which are not based on costly recombinant proteins. The company was founded by Errik B. Anderson, Warren Kett, Tillman U. Gerngross, Kevin Isett and Jonathan Sheller in 2012 and is headquartered in Lebanon, NH.

Part of Biosynth Holding AG, vivitite LLC is a provider of custom peptides, antibody services, and catalog products for the life science and biotech industry. The company is based in Gardner, MA, with significant operations in KY. Vivitide was founded in 2019, and Martina Diekmann has been the CEO of the company since 2020. Committed to outstanding quality and customer service, vivitide provides a broad portfolio of custom peptide synthesis services, custom antibodies, catalog peptides, and biochemicals to academia, pharmaceutical, biotech, and diagnostic companies worldwide. Vivitite LLC was acquired by Biosynth Carbosynth, part of Biosynth Holding AG from April 08, 2022 on March 17, 2022.